{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:31:43Z","timestamp":1772155903711,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/inf.0b013e318259fc8a","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T07:50:02Z","timestamp":1337759402000},"page":"e133-e140","source":"Crossref","is-referenced-by-count":23,"title":["Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age"],"prefix":"10.1097","volume":"31","author":[{"given":"Mark M.","family":"Blatter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie S.","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice A.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Varman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Grogg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Cambron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Douha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouzama","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R4-18-20210202","first-page":"S131","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.","volume":"189","author":"Zhou","year":"2004","journal-title":"J Infect Dis"},{"issue":"RR-8","key":"R5-18-20210202","first-page":"1","article-title":"Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.","volume":"331","author":"Peltola","year":"1994","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/377693","article-title":"Measles elimination in the United States.","volume":"189","author":"Orenstein","year":"2004","journal-title":"J Infect Dis"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination.","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.","volume":"19","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges.","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile.","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpedi.1994.02170090057008","article-title":"Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.","volume":"148","author":"Dietz","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"RR-7","key":"R14-18-20210202","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF01317822","article-title":"Sensitive neutralization test for virus antibody. 1. Mumps antibody.","volume":"58","author":"Sato","year":"1978","journal-title":"Arch Virol"},{"key":"R20-18-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CVI.00289-09","article-title":"Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.","volume":"17","author":"Poolman","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","article-title":"Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.","volume":"35","author":"Goh","year":"2007","journal-title":"Infection"},{"key":"R22-18-20210202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","article-title":"Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.","volume":"166","author":"Zepp","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0264-410X(00)00500-4","article-title":"Using in silico transcriptomics to search for tumor-associated antigens for immunotherapy.","volume":"19","author":"Vinals","year":"2001","journal-title":"Vaccine"},{"key":"R24-18-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Study Group for ProQuad. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).","volume":"2","author":"Kuter","year":"2006","journal-title":"Hum Vaccin"},{"key":"R25-18-20210202","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/S0264-410X(02)00245-1","article-title":"A comparison of safety, tolerability and immunogenicity of OkaMerck varicella vaccine and VARILRIX in healthy children.","volume":"20","author":"Lau","year":"2002","journal-title":"Vaccine"},{"key":"R26-18-20210202","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres.","volume":"28","author":"Spackova","year":"2010","journal-title":"Vaccine"},{"key":"R27-18-20210202","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: a household contact study.","volume":"292","author":"Seward","year":"2004","journal-title":"JAMA"},{"issue":"RR-3","key":"R28-18-20210202","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R29-18-20210202","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.","volume":"27","author":"Schuster","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R30-18-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R31-18-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"key":"R32-18-20210202","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"key":"R33-18-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1542\/peds.2011-1968","article-title":". Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.","volume":"128","year":"2011","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201208000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:02:15Z","timestamp":1618020135000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201208000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318259fc8a","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717597821.793153207","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717597821.793002879","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}